Pre-Approval Inspection (PAI) Readiness

To date, we have had a 100% success rate on PAI Readiness projects for our clients.

Our team of experts is equipped to guide you through every step of any Inspection, especially Pre-Approval Inspections, due to the nature of their criticality.

Ensure Your Product's Path to Market with Expert PAI Support

We ensure that every step towards Inspection Readiness is carefully calibrated to your needs. Our method is backed by tangible tools and training programs developed from the ground up, tailored not just to your product, but to your organization's unique scale and scope. This approach allows you to maintain focus on running your business, while we dedicate ourselves fully to your Inspection Readiness, making it our singular priority.

Gloved worker working with beakers in a laboratory

Inspection Readiness Evaluation / Gap Assessment

Our industry experts will audit and evaluate all aspects of your organization that are vital to a filing and commercialization - Quality Management Systems (QMS), Development, Manufacturing, Laboratories, etc. Additionally, we can provide similar evaluations of your CROs, CMOs, and Testing Laboratories. It is important to note that any organization listed in the filing is subject to inspection and should prepare.

ProPharma will produce a report outlining observation criticality and recommendations to aid in remediation and optimization efforts for your firm.

Collaborative, connected, and global

Project Management

Project Management

Checkmark icon

Remediation and Optimization

Remediation and Optimization

Program and project management icon

Develop an Inspection Program or Optimize Existing Program

Develop an Inspection Program or Optimize Existing Program

Innovation icon

Training

Training

Signal management icon

Mock Inspections

Mock Inspections

Adverse event intake icon

Post-Readiness Activities

Post-Readiness Activities

Project Management

Project Management is critical to the success of every project. No example is better than the importance of Project Management for PAI Readiness. Inspection Readiness has a multitude of simultaneous and associated activities. These activities include assessments and evaluations, remediation and optimization, logistics planning and execution, training, mock inspections, etc. And, of course, there is the ever present need to conduct "business as usual" concurrently. The everyday work does not stop while a firm is getting "Inspection Ready". The Project Manager will initiate, plan, and monitor all readiness activities with quality, budget, and timeline in mind .

Business worker working around a conference table

Remediation and Optimization

As an outcome of the Inspection Readiness Evaluation or other gap assessments, remediation or optimizations efforts with respect to policies, procedures, practices, documentation, facilities, etc. will likely be required. These activities can vary in size, criticality, or effort. Teaming with ProPharma for your firm’s remediation and optimization needs puts your firm closer to the finish line on your road to filing and Inspection Readiness. We have the experience and expertise to help guide you through the activities and ensure compliance and quality are maintained throughout.

Person wearing protective equipment reviewing a tablet device

Develop an Inspection Program or Optimize Existing Program

ProPharma can create Standard Operating Procedures (SOPs) on how inspections are handled at your organization and/or vendor organization. We can implement request and response processes (paper-based or electronic). We can develop all of the tools necessary for a successful PAI. Alternatively, we can review your existing Inspection processes and optimize them as necessary.

healthcare-workers-labcoats-reviewing-papers-near-computer-monitor-ss-46716574-650x425

Training

ProPharma can provide and execute various trainings to ensure Inspection Readiness. The entire organization will be trained on why PAIs occur and what to expect. Additionally, SMEs require and benefit from training on proper interviewing skills and responses to Inspectors’ questions. And finally, the Inspection Management Team’s training on roles, responsibilities, and their deliverables to ensure a smooth inspection experience for all.

customer-service-professional-wearing-headset-asking-coworker-a-question-ss-2149603273

Mock Inspections

ProPharma has helped many organizations plan and execute Mock Inspections with utilization of our former FDA investigators as well as our industry experts. Mock Inspections help ensure that the implementation, remediation, or optimization of processes has been a worthwhile effort as well as ensuring training on Inspection behavior has been successful.

Health care professionals reviewing x-ray scans on large television

Post-Readiness Activities

  • Inspection Support: Take a role in your inspection, as a part of your Inspection Management Team
  • Response Support: ProPharma is adept with Agency responses to observations, utilizing a holistic and S.M.A.R.T. approach (Specific, Measurable, Attainable, Relevant, and Timebound)
  • Additional remediation activities support
Group of professional women talking in a lobby

ProPharma can Provide and Support Your PAI Needs

Inspection readiness, whether it be a PAI or other Regulatory Inspection, is both a mindset and a practice. ProPharma can help you get there using one or all of our full suite of Inspection Readiness offerings. From Inspection Readiness Evaluations through to supporting you onsite or remotely during your PAI, we are your partner. And as your partner, we are highly skilled, collaborative, and dynamic.

Key focus areas for PAIs are far reaching. Among the most critical are:

  • Firm's ability to produce the product as outlined in the filing, readiness for commercialization
  • Quality System in place for the control of commercial operations
  • Robust Quality Management System (QMS)
  • Oversight of third party vendors/suppliers (Supplier qualification program)
  • Data Integrity
  • Quality product development program
Two professionals reviewing details on a computer monitor

Expert-Driven Pre-Approval Inspection

ProPharma is an industry leader helping companies ensure regulatory complianceWhether it be for Project Management, Mock PAI, PAI Readiness, Inspection Response or any other Quality, Regulatory or Inspection needs, we are the company you can rely on to be your partner.  

Want to learn more about PAI and Inspection Readiness?

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Facing a pending filing and subsequent PAI can feel overwhelming, no matter if you are a young firm or an established company. You're balancing the excitement of bringing a new product to market with...

Pre-Approval Inspection (PAI): What it is and How to Prepare

Pre-Approval Inspection (PAI): What it is and How to Prepare

What is a Pre-Approval Inspection (PAI)? A pre-approval inspection (PAI) is performed to provide the Food and Drug Administration (FDA) assurances that a manufacturing site named in a drug...

How to Ensure Your Device, Software, and Drug Are All Ready for a Pre-Approval Inspection

How to Ensure Your Device, Software, and Drug Are All Ready for a Pre-Approval Inspection

When drug or device manufacturers apply for marketing approval of a new product, the FDA may conduct a pre-approval inspection (PAI). The PAI is performed to help the Agency assure that a...

News & Insights

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

Navigating EMA and Global Regulations for Medical Information Services

July 24, 2025

Navigating EMA and Global Regulations for Medical Information Services

ProPharma guides clients through global medical information regulatory landscapes, ensuring compliance and excellence across markets with tailored solutions, AI integration, and continuous training.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study From Drafts to First Patient in Record Time - ProPharma

July 8, 2025

From Drafts to First Patient in Record Time

Launching a global clinical study from draft documents, the team achieved US first patient in in 3.5 months and met ambitious global submission timelines. Strong collaboration, proactive planning,...

Whitepapers FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submission

June 23, 2025

FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submiss...

A Strategic Guide to Early FDA Engagement for a Streamlined NDA Pathway For drug developers leveraging the 505(b)(2) NDA pathway, early engagement with FDA is a critical determinant of regulatory...

Case Study Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina - ProPharma

June 18, 2025

Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina

Acting as Marketing Authorization Holder in Bosnia and Herzegovina, Clinres—a ProPharma company—helped a global pharma client overcome regulatory delays, misaligned planning, and seasonal launch...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

Navigating EMA and Global Regulations for Medical Information Services

July 24, 2025

Navigating EMA and Global Regulations for Medical Information Services

ProPharma guides clients through global medical information regulatory landscapes, ensuring compliance and excellence across markets with tailored solutions, AI integration, and continuous training.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study From Drafts to First Patient in Record Time - ProPharma

July 8, 2025

From Drafts to First Patient in Record Time

Launching a global clinical study from draft documents, the team achieved US first patient in in 3.5 months and met ambitious global submission timelines. Strong collaboration, proactive planning,...

Whitepapers FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submission

June 23, 2025

FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submiss...

A Strategic Guide to Early FDA Engagement for a Streamlined NDA Pathway For drug developers leveraging the 505(b)(2) NDA pathway, early engagement with FDA is a critical determinant of regulatory...

Case Study Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina - ProPharma

June 18, 2025

Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina

Acting as Marketing Authorization Holder in Bosnia and Herzegovina, Clinres—a ProPharma company—helped a global pharma client overcome regulatory delays, misaligned planning, and seasonal launch...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow